SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
Despite a downturn in the CAS spine market and a decrease in the proportion of robotic spine cases in Q2...
Calibrating the craziness and uncertainties of a roller coaster quarter Because Orthobiologics spans var...
With plans to become a stroke strategic, Imperative Care Chairman and CEO Fred Khosravi discusses elevat...
The effects of COVID-19 were felt throughout the WW Spine Market with dramatic Q220 declines in both the...
Q220 reflects the full impact of COVID-19, driving a downward slide in all segments For Q220, according ...
Mark Dickinson, Worldwide President of Cerenovus, discusses the Company’s focus on patients, innovation ...
Heavy-weight contender COVID-19 landed some brutal blows to revenue in Q220, but companies look for bett...
In Q220, all geographies experienced shrinkage in their AWC revenues with Single-use NPWT showing the sh...
Keith Boettiger, Vice President, Neuromodulation, Abbott discusses COVID-19 and the Company’s strategies...
We are pleased to announce that Tim Patrick has joined the team at SmartTRAK as Senior Manager of Corpor...
Login